Literature DB >> 11931771

Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing.

Nicolas Charlet-B1, Penny Logan, Gopal Singh, Thomas A Cooper.   

Abstract

Inclusion of cardiac troponin T (cTNT) exon 5 in embryonic muscle requires conserved flanking intronic elements (MSEs). ETR-3, a member of the CELF family, binds U/G motifs in two MSEs and directly activates exon inclusion in vitro. Binding and activation by ETR-3 are directly antagonized by polypyrimidine tract binding protein (PTB). We use dominant-negative mutants to demonstrate that endogenous CELF and PTB activities are required for MSE-dependent activation and repression in muscle and nonmuscle cells, respectively. Combined use of CELF and PTB dominant-negative mutants provides an in vivo demonstration that antagonistic splicing activities exist within the same cells. We conclude that cell-specific regulation results from the dominance of one among actively competing regulatory states rather than modulation of a nonregulated default state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931771     DOI: 10.1016/s1097-2765(02)00479-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

1.  U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA.

Authors:  Hui Zhu; Robert A Hasman; Katherine M Young; Nancy L Kedersha; Hua Lou
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 2.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

3.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

Review 4.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

5.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.

Authors:  Shalini Sharma; Arnold M Falick; Douglas L Black
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

Review 6.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

Review 7.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

8.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

9.  A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart.

Authors:  Junmei Ye; Miriam Llorian; Maria Cardona; Anthony Rongvaux; Rana S Moubarak; Joan X Comella; Rhonda Bassel-Duby; Richard A Flavell; Eric N Olson; Christopher W J Smith; Daniel Sanchis
Journal:  J Cell Sci       Date:  2013-02-19       Impact factor: 5.285

10.  A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG.

Authors:  Yui Jin; Hitoshi Suzuki; Shingo Maegawa; Hitoshi Endo; Sumio Sugano; Katsuyuki Hashimoto; Kunio Yasuda; Kunio Inoue
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.